18F-Radiolabeled Translocator Protein (TSPO) PET Tracers: Recent Development of TSPO Radioligands and Their Application to PET Study

TG Luu, HK Kim - Pharmaceutics, 2022 - mdpi.com
Translocator protein 18 kDa (TSPO) is a transmembrane protein in the mitochondrial
membrane, which has been identified as a peripheral benzodiazepine receptor. TSPO is …

Selenium-based drug development for antioxidant and anticancer activity

S Debnath, A Agarwal, NR Kumar, A Bedi - Future Pharmacology, 2022 - mdpi.com
Selenium is one of the eight necessary trace elements humans require for active health
balance. It contributes in several ways to the proper functioning of selenoprotein. Selenium …

One-Pot formal carboradiofluorination of alkenes: a toolkit for positron emission tomography imaging probe development

M Rivas, S Debnath, S Giri, YM Noffel… - Journal of the …, 2023 - ACS Publications
We report the first one-pot formal alkene carboradiofluorination reaction employing easily
accessible alkenes as both prosthetic group precursors and coupling partners. The …

Preclinical efficacy of a PARP-1 targeted Auger-emitting radionuclide in prostate cancer

S Sreekumar, D Zhou, C Mpoy, E Schenk… - International journal of …, 2023 - mdpi.com
There is an unmet need for better therapeutic strategies for advanced prostate cancer. Poly
(ADP-ribose) polymerase-1 (PARP-1) is a chromatin-binding DNA repair enzyme …

BODIPY-based molecules for biomedical applications

S Das, S Dey, S Patra, A Bera, T Ghosh, B Prasad… - Biomolecules, 2023 - mdpi.com
BODIPY (4, 4-difluoro-4-bora-3a, 4a-diaza-s-indacene) derivatives have attracted attention
as probes in applications like imaging and sensing due to their unique properties like (1) …

[HTML][HTML] A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer

P Gonzalez, S Debnath, YA Chen, E Hernandez, P Jha… - Pharmaceutics, 2023 - mdpi.com
After androgen deprivation therapy, a significant number of prostate cancer cases progress
with a therapy-resistant neuroendocrine phenotype (NEPC). This represents a challenge for …

Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment

T Wang, M Li, R Wei, X Wang, Z Lin… - Molecular …, 2024 - ACS Publications
Antibody drug conjugates (ADCs) have emerged as a new promising class of anti-cancer
agents. However, limitations such as higher costs and unavoidable immunogenicity due to …

Claudin-3 loss of expression is a prognostic marker in castration-resistant prostate cancer

MJ Orea, JC Angulo, A González-Corpas… - International Journal of …, 2023 - mdpi.com
Castration-resistant prostate cancer (CRPC) development is the foremost concern after
treatment of patients with high risk with locally advanced or metastatic prostate cancer …

Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology

L He, MY Zhang, M Cox, Q Zhang… - ACS Medicinal …, 2024 - ACS Publications
Small molecule toll-like receptor (TLR) 7 agonists have gathered considerable interest as
promising therapeutic agents for applications in cancer immunotherapy. Herein, we describe …

Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein …

R Yin, KX Huang, LA Huang, M Ji, H Zhao, K Li, A Gao… - Pharmaceuticals, 2023 - mdpi.com
Recently, growing evidence of the relationship between G-protein coupled receptor 44
(GPR44) and the inflammation-cancer system has garnered tremendous interest, while the …